Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
Media-OutReach Newswire Lao Brewery Company Strengthens Commitment to a Greener Future with Renewable Energy and Sustainability Initiatives
World Lao government to hold perpetrators accountable for suspected methanol poisoning of foreign tourists